SGI
ANIP icon

Summit Global Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Summit Global Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,306
Closed -$1.09M – 464
2025
Q1 		$1.09M Sell
16,306
-3,200
-16% -$191K 0.08% 159
2024
Q4 		$1.08M Sell
19,506
-198
-1% -$11.4K 0.07% 202
2024
Q3 		$1.18M Buy
19,704
+11,952
+154% +$729K 0.08% 219
2024
Q2 		$494K Sell
7,752
-7,390
-49% -$480K 0.03% 351
2024
Q1 		$1.05M Buy
15,142
+1,115
+8% +$67.3K 0.08% 201
2023
Q4 		$773K Buy
+14,027
New +$772K 0.05% 268

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Summit Global Investments's ANIP Position: Q2 2025 in Review

Summit Global Investments sold out of ANI Pharmaceuticals (ANIP) in Q2 2025, closing a stake of 16,306 shares — an estimated $1.09M sold.

Summit Global Investments first reported a position in ANIP in Q4 2023 and held it in 6 quarters. The position peaked at $1.18M in Q3 2024. 232 funds tracked by Wall St. Rank hold ANIP as of Q2 2025.

  • Summit Global Investments reported no remaining ANI Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Summit Global Investments sold 16,306 ANI Pharmaceuticals shares in Q2 2025, an estimated $1.09M.
  • Summit Global Investments first reported a position in ANI Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • Summit Global Investments's ANI Pharmaceuticals position peaked at $1.18M in Q3 2024.
  • 232 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2025.

Based on Summit Global Investments's 13F filing for Q2 2025, filed 12 Aug 2025.